PHAXIAM Therapeutics S.A. (PHXM.PA)

EUR 1.73

(-0.57%)

Total Debt Summary of PHAXIAM Therapeutics S.A.

  • PHAXIAM Therapeutics S.A.'s latest annual total debt in 2023 was 10.19 Million EUR , down -1.94% from previous year.
  • PHAXIAM Therapeutics S.A.'s latest quarterly total debt in 2024 Q2 was 10.86 Million EUR , down 0.0% from previous quarter.
  • PHAXIAM Therapeutics S.A. reported annual total debt of 13.52 Million EUR in 2022, down -32.55% from previous year.
  • PHAXIAM Therapeutics S.A. reported annual total debt of 20.05 Million EUR in 2021, down -26.84% from previous year.
  • PHAXIAM Therapeutics S.A. reported quarterly total debt of 10.86 Million EUR for 2024 Q2, down 0.0% from previous quarter.
  • PHAXIAM Therapeutics S.A. reported quarterly total debt of 10.19 Million EUR for 2023 Q4, down 0.0% from previous quarter.

Annual Total Debt Chart of PHAXIAM Therapeutics S.A. (2023 - 2016)

Historical Annual Total Debt of PHAXIAM Therapeutics S.A. (2023 - 2016)

Year Total Debt Total Debt Growth
2023 10.19 Million EUR -1.94%
2022 13.52 Million EUR -32.55%
2021 20.05 Million EUR -26.84%
2020 27.41 Million EUR 94.61%
2019 14.08 Million EUR 597.67%
2018 2.01 Million EUR -28.98%
2017 2.84 Million EUR -0.8%
2016 2.86 Million EUR 0.0%

Peer Total Debt Comparison of PHAXIAM Therapeutics S.A.

Name Total Debt Total Debt Difference
Nicox S.A. 25.15 Million EUR 59.452%
European Medical Solutions 18.13 Million EUR 43.748%
FERMENTALG 15.35 Million EUR 33.574%